Device costs in Atrial Fibrilation ablation procedures are substantial and often more than half of CMS reimbursement ($21,916 in 2022), potentially cutting into profitability. At the same time, the extensive use of single-use devices in AFib ablation has negative impact on the environment. Device reuse (reprocessing) offers a way to reduce the percentage spent on devices as well as environmental impact. To determine the potential device cost impact of a comprehensive device reuse (reprocessing) program and determine its impact on the percentage of reimbursement spent on devices in an Atrial Fibrilation ablation procedure. Additionally, to determine the difference in environmental footprint between an Atrial Fibrilation procedure that uses reprocessed devices versus one that does not. The study combined the use of EP leadership interviews, price databases, GUDID and CMS databases, and secondary research. Initially, we interviewed EP lab leaders about devices used in most AFib Ablation procedures, then hospitals with comprehensive reprocessing programs provided prices for new devices and reprocessed devices. Since prices vary between brands, we used prices for the market leading brands. For the purpose of showing maximum potential impact (a comprehensive reprocessing program), we included all devices that can be reprocessed, per the GUDID database, and CMS tables provided us with the 2022 MediCare/MedicAid reimbursement for Atrial Fibrilation. Secondary research provided estimates of the carbon emission impact of new versus reprocessed EP devices. Using reprocessed devices in an Atrial Fibrilation ablation procedure can reduce device costs by more than 30% or approximately $3,250. This reduces the device cost burden on reimbursement from 48% to 33%. Studies show that using a reprocessed device reduces the carbon footprint of an electrophysiology device by 1.94 pounds. In an Atrial Fibrilation ablation procedure, we estimate the reduction in carbon emissions to be 13.6 Lbs or more than 2,000 Lbs per year for a facility that does 150 AFib ablations per year. Employing a comprehensive reprocessing program in AFib procedures can reduce the high device cost share of reimbursement, potentially reducing loss/adding profitability, and freeing resources to acquire new technology, expand patient access, and more.